TP53 and gastric cancer: One recent study reported that VCAN-AS1 could downregulate the expression of TP53 and promote the progress of GC by interacting with eIF4A3 while silencing VCAN-AS1 could inhibit cell proliferation, migration, and invasion but enhance apoptosis [15].